Table 2 Patient characteristics
Low-dose landiolol | High-dose landiolol | Propranolol | P value | |
|---|---|---|---|---|
(n = 188) | (n = 213) | (n = 277) | ||
Age | 67.6 ± 10.9 | 67.7 ± 11.1 | 67.0 ± 11.9 | 0.76 |
Male gender | 104 (55.3%) | 120 (56.3%) | 155 (56.0%) | 0.98 |
Height, cm | 159.3 ± 8.5 | 159.3 ± 9.2 | 159.7 ± 9.2 | 0.90 |
Weight, kg | 60.6 ± 11.3 | 60.5 ± 11.9 | 61.4 ± 12.9 | 0.67 |
<70 kg | 149 (79.3%) | 168 (78.9%) | 215 (77.6%) | 0.90 |
≥70 kg | 39 (20.7%) | 45 (21.1%) | 62 (22.4%) | |
Body mass index | 23.8 ± 3.3 | 23.7 ± 3.4 | 23.9 ± 3.8 | 0.73 |
HR before β-blocker, min-1 | 72.9 ± 7.3 | 72.1 ± 7.7 | 72.5 ± 7.7 | 0.61 |
<75/min | 111 (59.0%) | 121 (56.8%) | 174 (62.8%) | 0.39 |
≥75/min | 77 (41.0%) | 92 (43.2%) | 103 (37.2%) |